(Reuters) – Johnson & Johnson expects to share details on the company’s late-stage COVID-19 vaccine trial early next week, Chief Executive Officer Alex Gorsky said at a post-earnings conference call on Tuesday.
(Reporting by Manas Mishra in Bengaluru; Editing by Shailesh Kuber)
